Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Concomitant“
Suchtreffer
Begriffe & Kennungen
Anoro Ellipta (previously Anoro) · 4.5 · Vilanterol is a substrate of cytochrome P450 3A4 (CYP3A4). Concomitant administration of strong CYP3A4 inhibit
Eintrag öffnenApixaban Accord · 4.5 · Apixaban is not recommended for the treatment of DVT and PE in patients receiving concomitant systemic treatme
Eintrag öffnenApixaban Accord · 4.5 · Other concomitant therapies No clinically significant pharmacokinetic or pharmacodynamic interactions were obs
Eintrag öffnenApixaban Accord · 4.5 · Other concomitant therapies No clinically significant pharmacokinetic or pharmacodynamic interactions were obs
Eintrag öffnenApixaban Accord · 4.5 · The use of apixaban is not recommended in patients receiving concomitant systemic treatment with strong inhibi
Eintrag öffnenApixaban Accord · 4.5 · The use of apixaban is not recommended in patients receiving concomitant systemic treatment with strong inhibi
Eintrag öffnenAprovel · 4.3 · The concomitant use of Aprovel with aliskiren-containing products is contraindicated in patients with diabetes
Eintrag öffnenAprovel · 4.3 · The concomitant use of Aprovel with aliskiren-containing products is contraindicated in patients with diabetes
Eintrag öffnenAprovel · 4.3 · The concomitant use of Aprovel with aliskiren-containing products is contraindicated in patients with diabetes
Eintrag öffnenAprovel · 4.3 · The concomitant use of Aprovel with aliskiren-containing products is contraindicated in patients with diabetes
Eintrag öffnenAprovel · 4.3 · The concomitant use of Aprovel with aliskiren-containing products is contraindicated in patients with diabetes
Eintrag öffnenAprovel · 4.3 · The concomitant use of Aprovel with aliskiren-containing products is contraindicated in patients with diabetes
Eintrag öffnenAprovel · 4.5 · As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk
Eintrag öffnenAprovel · 4.5 · As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk
Eintrag öffnenAprovel · 4.5 · As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk
Eintrag öffnenAprovel · 4.5 · As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk
Eintrag öffnenAprovel · 4.5 · As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk
Eintrag öffnenAprovel · 4.5 · As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk
Eintrag öffnenAptivus · 4.3 · 3 Combination of rifampicin with Aptivus with concomitant low dose ritonavir is contraindicated (see section 4
Eintrag öffnenAptivus · 4.5 · 11 Lopinavir/ritonavir Lopinavir Cmax ↓ 47% The concomitant use of Aptivus, 400/100 mg BID Lopinavir AUC ↓ 55%
Eintrag öffnen